These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32959695)

  • 1. MiR-32-5p knockdown inhibits epithelial to mesenchymal transition and renal fibrosis by targeting SMAD7 in diabetic nephropathy.
    Wang HJ; Liu H; Lin YH; Zhang SJ
    Hum Exp Toxicol; 2021 Apr; 40(4):587-595. PubMed ID: 32959695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
    Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
    Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
    Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
    Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-17 suppresses TGF-β1-mediated renal fibrosis through targeting Smad7.
    Fu H; Chu D; Geng X
    Mol Cell Biochem; 2021 Aug; 476(8):3051-3064. PubMed ID: 33797702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
    McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
    Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_WBSCR17 aggravates inflammatory responses and fibrosis by targeting miR-185-5p/SOX6 regulatory axis in high glucose-induced human kidney tubular cells.
    Li G; Qin Y; Qin S; Zhou X; Zhao W; Zhang D
    Life Sci; 2020 Oct; 259():118269. PubMed ID: 32798559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy.
    Gao BH; Wu H; Wang X; Ji LL; Chen C
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis.
    Liu B; Qiang L; Wang GD; Duan Q; Liu J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
    Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
    Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy.
    Meng Q; Zhai X; Yuan Y; Ji Q; Zhang P
    Braz J Med Biol Res; 2020; 53(4):e9288. PubMed ID: 32294702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells.
    Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM
    Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.
    Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icariin inhibits epithelial mesenchymal transition of renal tubular epithelial cells via regulating the miR-122-5p/FOXP2 axis in diabetic nephropathy rats.
    Zang L; Gao F; Huang A; Zhang Y; Luo Y; Chen L; Mao N
    J Pharmacol Sci; 2022 Feb; 148(2):204-213. PubMed ID: 35063135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Dodecyl-6-Methoxycyclohexa-2, 5-Diene-1, 4-Dione isolated from Averrhoa carambola L. root inhibits high glucose-induced EMT in HK-2 cells through targeting the regulation of miR-21-5p/Smad7 signaling pathway.
    Li J; Pang Q; Huang X; Jiang H; Tang G; Yan H; Guo Y; Yan X; Li L; Zhang H
    Biomed Pharmacother; 2024 Mar; 172():116280. PubMed ID: 38368837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.
    Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z
    Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.
    Du L; Qian X; Li Y; Li XZ; He LL; Xu L; Liu YQ; Li CC; Ma P; Shu FL; Lu Q; Yin XX
    Acta Pharmacol Sin; 2021 Feb; 42(2):242-251. PubMed ID: 32555442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy.
    Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C
    Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p.
    Fu JX; Sun GQ; Wang HL; Jiang HX
    J Biol Regul Homeost Agents; 2020; 34(3):961-968. PubMed ID: 32519534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
    Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
    J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.